0,796  0,005  Chemopreventive
0,779  0,003  Monophenol monooxygenase inhibitor
0,771  0,004  NOS2 expression inhibitor
0,748  0,013  Antineoplastic (lung cancer)
0,736  0,005  CYP1A2 inhibitor
0,729  0,005  Lipoxygenase inhibitor
0,721  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,699  0,003  Melanin inhibitor
0,700  0,020  Transcription factor NF kappa B inhibitor
0,683  0,006  AR expression inhibitor
0,677  0,004  Skin whitener
0,684  0,034  Antiinflammatory
0,653  0,017  15-Lipoxygenase inhibitor
0,668  0,036  Apoptosis agonist
0,634  0,009  NOS3 expression inhibitor
0,635  0,010  Spasmolytic
0,618  0,010  Antioxidant
0,614  0,007  Antiprotozoal (Leishmania)
0,608  0,008  Free radical scavenger
0,623  0,031  Antineoplastic (breast cancer)
0,599  0,010  Cardioprotectant
0,571  0,010  Hypoglycemic
0,569  0,028  Antileukemic
0,543  0,013  Nitric oxide antagonist
0,533  0,005  NOS3 expression enhancer
0,529  0,010  Vasodilator
0,524  0,018  Hepatic disorders treatment
0,520  0,016  Antineoplastic (glioma)
0,520  0,022  Antineoplastic (melanoma)
0,514  0,019  Cytostatic
0,525  0,032  Antineoplastic (colorectal cancer)
0,509  0,032  Antineoplastic (colon cancer)
0,495  0,020  Antineoplastic (brain cancer)
0,507  0,046  Alzheimer's disease treatment
0,482  0,030  Antineoplastic (ovarian cancer)
0,451  0,004  Electron transport complex I inhibitor
0,448  0,007  Lipid peroxidase inhibitor
0,461  0,024  UGT1A9 substrate
0,442  0,008  Platelet adhesion inhibitor
0,463  0,031  Antihypercholesterolemic
0,435  0,022  Antipyretic
0,471  0,059  Antidiabetic
0,471  0,059  Cyclophilin D inhibitor
0,407  0,008  Protein-tyrosine phosphatase inhibitor
0,403  0,005  Heat shock protein 90 alpha antagonist
0,401  0,004  Heat shock protein 90 antagonist
0,428  0,033  Antiischemic
0,451  0,056  Antibacterial
0,396  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,411  0,026  Antineoplastic (glioblastoma multiforme)
0,408  0,023  Antidiabetic symptomatic
0,404  0,035  Antineoplastic (cervical cancer)
0,395  0,038  Antiosteoporotic
0,368  0,015  Antihypotensive
0,384  0,032  Proliferative diseases treatment
0,377  0,027  Antimitotic
0,408  0,058  CYP2C19 inhibitor
0,371  0,024  Antineoplastic (lymphocytic leukemia)
0,359  0,014  Tubulin antagonist
0,371  0,029  Antiparasitic
0,384  0,051  Streptokinase A inhibitor
0,344  0,014  Topoisomerase II inhibitor
0,347  0,023  Antihelmintic
0,348  0,024  RNA-directed DNA polymerase inhibitor
0,376  0,056  Bone diseases treatment
0,358  0,042  Antidiabetic (type 2)
0,353  0,050  CYP3A4 inhibitor
0,338  0,044  DNA damaging
0,357  0,063  Prostate cancer treatment
0,310  0,016  Genotoxic
0,352  0,061  ICAM1 expression inhibitor
0,318  0,034  Antihypertriglyceridemic
0,355  0,076  CYP3A4 substrate
0,300  0,023  Diabetic retinopathy treatment
0,293  0,019  Sepsis treatment
0,309  0,038  Antineoplastic (sarcoma)
0,282  0,012  5-Lipoxygenase inhibitor
0,367  0,101  5 Hydroxytryptamine release inhibitor
0,297  0,031  Hepatoprotectant
0,282  0,020  UGT2B15 substrate
0,325  0,072  Antihypertensive
0,320  0,069  12-Lipoxygenase inhibitor
0,320  0,072  Vasodilator, coronary
0,308  0,067  CTGF expression inhibitor
0,303  0,064  Antineoplastic (multiple myeloma)
0,287  0,048  UGT1A6 substrate
0,310  0,074  Caspase 3 stimulant
0,303  0,067  Lipoprotein disorders treatment
0,240  0,005  Actinic keratosis treatment
0,290  0,056  Platelet antagonist
0,271  0,040  UGT1A1 substrate
0,258  0,029  Antineoplastic (squamous cell carcinoma)
0,297  0,068  Radioprotector
0,334  0,108  TNF expression inhibitor
0,234  0,008  Phosphodiesterase 4D inhibitor
0,323  0,099  CYP2C9 inhibitor
0,286  0,062  Cardiotonic
0,226  0,004  Ornithine decarboxylase inhibitor
0,357  0,140  Caspase 9 stimulant
0,322  0,109  Antiprotozoal
0,250  0,038  Neurotrophic factor enhancer
0,257  0,047  UDP-glucuronosyltransferase substrate
0,267  0,057  Cytotoxic
0,243  0,040  CYP2B6 inhibitor
0,285  0,085  Antimycobacterial
0,207  0,009  Urease inhibitor
0,208  0,012  Estrogen antagonist
0,302  0,106  Ulceration
0,262  0,072  Antineoplastic (non-small cell lung cancer)
0,262  0,075  Transcription factor STAT3 inhibitor
0,193  0,008  Postmenopausal disorders treatment
0,197  0,013  Phosphodiesterase IV inhibitor
0,195  0,011  Papain-like protease (SARS coronavirus) inhibitor
0,281  0,099  Apoptosis antagonist
0,257  0,075  Antineoplastic (renal cancer)
0,259  0,085  Antituberculosic
0,233  0,060  Antiarrhythmic
0,268  0,098  Antifungal
0,182  0,011  Estrogen receptor beta antagonist
0,179  0,009  Estrogen receptor alpha antagonist
0,174  0,009  Estrogen agonist
0,196  0,034  Acetylcholinesterase inhibitor
0,202  0,041  Protein kinase stimulant
0,250  0,090  UGT2B4 substrate
0,201  0,043  Antiviral (Influenza A)
0,175  0,020  Gastritis treatment
0,297  0,143  Antiparkinsonian
0,244  0,091  Transcription factor STAT inhibitor
0,192  0,046  Interleukin 6 antagonist
0,163  0,019  Carbonic anhydrase XIII inhibitor
0,170  0,028  Beta amyloid protein antagonist
0,170  0,034  Topoisomerase I inhibitor
0,221  0,086  Antiamyloidogenic
0,170  0,035  Farnesoid X receptor antagonist
0,188  0,052  Cholinergic
0,233  0,099  Chemoprotective
0,162  0,028  Bronchodilator
0,183  0,050  Antiischemic, cerebral
0,159  0,029  Antiemetic
0,187  0,058  UGT1A3 substrate
0,192  0,069  VEGF expression inhibitor
0,177  0,054  Antineoplastic (carcinoma)
0,238  0,116  GST M1-1 substrate
0,192  0,070  P-glycoprotein inhibitor
0,204  0,084  VCAM1 expression inhibitor
0,258  0,142  CYP2C9 substrate
0,205  0,089  Antineoplastic (lymphoma)
0,141  0,025  Topoisomerase II alpha inhibitor
0,154  0,039  Glutathione S-transferase substrate
0,123  0,009  Estrogen receptor beta agonist
0,165  0,057  Antidiarrheal
0,114  0,006  Potassium channel Kv1.3 blocker
0,188  0,082  Antiviral (Influenza)
0,191  0,086  Pyruvate kinase inhibitor
0,149  0,045  Cholesterol synthesis inhibitor
0,129  0,026  NAD(P)H dehydrogenase (quinone) inhibitor
0,206  0,103  Myocardial infarction treatment
0,148  0,048  Antihemorrhagic
0,166  0,068  Antimutagenic
0,252  0,154  Histamine release inhibitor
0,121  0,029  SULT1E1 substrate
0,114  0,023  Keratolytic
0,148  0,060  Antifungal enhancer
0,171  0,084  Antirickettsial
0,241  0,156  Immunosuppressant
0,098  0,016  Neuraminidase inhibitor
0,179  0,097  Pneumotoxic
0,087  0,005  Liver X receptor antagonist
0,235  0,153  Antiprotozoal (Plasmodium)
0,244  0,162  Antiobesity
0,154  0,073  Interferon gamma antagonist
0,152  0,072  Insulin secretagoues
0,157  0,080  Arachidonic acid antagonist
0,105  0,028  Na+ K+ transporting ATPase inhibitor
0,238  0,161  Calcium channel activator
0,139  0,064  Cyclooxygenase 1 inhibitor
0,182  0,108  Hypolipemic
0,156  0,083  UGT2B7 substrate
0,085  0,014  Transcription factor RelA inhibitor
0,117  0,046  Dementia treatment
0,112  0,041  Antineoplastic antibiotic
0,094  0,024  Phosphodiesterase VI inhibitor
0,102  0,033  5 Hydroxytryptamine agonist
0,116  0,049  Butyrylcholinesterase inhibitor
0,122  0,056  Cystathionine beta-synthase inhibitor
0,137  0,071  Contraceptive
0,126  0,061  Contraceptive female
0,111  0,046  Vascular dementia treatment
0,160  0,096  Antineoplastic (bone cancer)
0,068  0,007  Retinoic acid alpha receptor agonist
0,172  0,111  Histone acetyltransferase inhibitor
0,154  0,093  UGT2B10 substrate
0,091  0,033  Peroxisome proliferator-activated receptor gamma agonist
0,154  0,101  Sedative
0,104  0,052  UGT2B11 substrate
0,071  0,019  5 Hydroxytryptamine 2 agonist
0,078  0,028  Aromatase inhibitor
0,079  0,030  Beta tubulin antagonist
0,172  0,124  Antiviral (HIV)
0,137  0,088  Heat shock protein 70 antagonist
0,102  0,054  Prolactin inhibitor
0,124  0,076  Antineoplastic (uterine cancer)
0,148  0,101  Carcinogenic
0,076  0,031  5 Hydroxytryptamine 2A agonist
0,137  0,096  UGT1A4 substrate
0,149  0,109  Catenin beta inhibitor
0,099  0,060  Xanthine oxidase inhibitor
0,081  0,042  Lipase inhibitor
0,149  0,112  LDLR expression enhancer
0,151  0,114  Non-steroidal antiinflammatory agent
0,127  0,091  Cyclooxygenase inhibitor
0,076  0,041  Secretase beta inhibitor
0,173  0,137  Antineoplastic (liver cancer)
0,042  0,008  Sodium/glucose cotransporter 2 inhibitor
0,093  0,060  ABCA1 expression enhancer
0,116  0,084  Cyclooxygenase 2 inhibitor
0,207  0,175  Antineoplastic (osteosarcoma)
0,068  0,038  Neuraminidase (influenza) inhibitor
0,162  0,134  Cyclic AMP phosphodiesterase inhibitor
0,068  0,040  HIV-1 integrase (3'-Processing) inhibitor
0,097  0,070  Gastric antisecretory
0,072  0,046  HIV-1 integrase inhibitor
0,095  0,069  Anabolic
0,033  0,009  Toll-Like receptor 4 agonist
0,157  0,133  Aldehyde oxidase inhibitor
0,039  0,016  Melatonin 2 agonist
0,132  0,109  Ca2+-transporting ATPase inhibitor
0,136  0,114  Sensitization
0,133  0,111  CF transmembrane conductance regulator agonist
0,065  0,044  Leukotriene antagonist
0,148  0,128  Abortion inducer
0,105  0,086  MAO inhibitor
0,060  0,042  HIV-1 integrase (Strand Transfer) inhibitor
0,225  0,208  Analgesic
0,169  0,154  Nitric-oxide synthase stimulant
0,028  0,013  Sodium/glucose cotransporter inhibitor
0,163  0,148  Vascular (periferal) disease treatment
0,125  0,111  UGT2B9 substrate
0,023  0,010  Retinoic acid alpha receptor antagonist
0,037  0,024  Retinoid X receptor agonist
0,195  0,182  Vasodilator, peripheral
0,044  0,033  5 Hydroxytryptamine 2C agonist
0,127  0,118  Antipruritic, non-allergic
0,017  0,007  Antibiotic Tetracycline-like
0,116  0,107  Mutagenic
0,046  0,037  Mineralocorticoid receptor antagonist
0,032  0,024  Estrogen-related receptor beta antagonist
0,173  0,167  CYP2C19 substrate
0,137  0,131  Angiogenesis stimulant
0,214  0,210  Antineoplastic (small cell lung cancer)
0,139  0,135  Succinate dehydrogenase inhibitor
0,081  0,078  Contraceptive male
0,021  0,019  Retinoic acid receptor agonist
0,041  0,039  Carbonic anhydrase VII inhibitor
0,154  0,153  Tumour necrosis factor alpha release inhibitor
0,086  0,084  Bile acid receptor antagonist
0,116  0,114  SULT1A3 substrate
0,162  0,161  Antiprotozoal (Trypanosoma)
0,071  0,070  Antitreponemal
0,094  0,094  CDC-like kinase 3 inhibitor

